ATRA
Atara Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.76
+2.41%Margins
Gross margin
91.4%
EBITDA margin
-220.4%
EBIT margin
-229.7%
Net margin
-269.4%
FCF margin
-353.5%
45.1%
Return on equity
-79.4%
Return on assets
52.5%
Return on invested capital
0.30x
Asset turnover
-$21.9M
Cash from operations
$0.98
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026